Axsome Therapeutics (AXSM) had the highest return between October 1, 2019 and December 30, 2019 by a mid-cap US stock, returning 412.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Axsome Therapeutics (AXSM) | 10/1/2019 - 12/30/2019 | 412.74% |
Intracellular Th (ITCI) | 10/1/2019 - 12/30/2019 | 351.81% |
Nio Inc Class A ADR (NIO) | 10/1/2019 - 12/30/2019 | 146.36% |
Arrowhead Pharmaceuticals (ARWR) | 10/1/2019 - 12/30/2019 | 128.47% |
Bloom Energy (BE) | 10/1/2019 - 12/30/2019 | 120.55% |
Surgery Partners (SGRY) | 10/1/2019 - 12/30/2019 | 108.94% |
TG Therapeutics (TGTX) | 10/1/2019 - 12/30/2019 | 92.38% |
Hecla Mining (HL) | 10/1/2019 - 12/30/2019 | 90.12% |
Sitime (SITM) | 10/1/2019 - 12/30/2019 | 87.46% |
Sibanye Gold Ltd ADR (SBSW) | 10/1/2019 - 12/30/2019 | 80.11% |
SpringWorks Therapeutics (SWTX) | 10/1/2019 - 12/30/2019 | 71.99% |
Central Puerto (CEPU) | 10/1/2019 - 12/30/2019 | 71.04% |
Coeur Mining (CDE) | 10/1/2019 - 12/30/2019 | 69.47% |
Krystal Biotech (KRYS) | 10/1/2019 - 12/30/2019 | 67.63% |
Synaptics (SYNA) | 10/1/2019 - 12/30/2019 | 65.66% |
BridgeBio Pharma (BBIO) | 10/1/2019 - 12/30/2019 | 64.99% |
Vipshop (VIPS) | 10/1/2019 - 12/30/2019 | 61.31% |
Gerdau SA ADR (GGB) | 10/1/2019 - 12/30/2019 | 57.79% |
Immunovant (IMVT) | 10/1/2019 - 12/30/2019 | 57.78% |
Companhia Paranaense de Energia Pref ADR (ELP) | 10/1/2019 - 12/30/2019 | 57.14% |
Qorvo (QRVO) | 10/1/2019 - 12/30/2019 | 56.36% |
Cirrus Logic (CRUS) | 10/1/2019 - 12/30/2019 | 55.09% |
Crinetics Pharmaceuticals (CRNX) | 10/1/2019 - 12/30/2019 | 54.16% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 10/1/2019 - 12/30/2019 | 54.11% |
Vicor (VICR) | 10/1/2019 - 12/30/2019 | 54.07% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
